FDA approves treatment that delays type 1 diabetes. It could be 'game changing'

Published Nov 21, 2022, 11:17 AM

A vial of TZIELD costs nearly $14,000, a notable price given the escalating cost of lifesaving insulin for people with diabetes.

USA TODAY

Get the latest news, sports, entertainment, money and tech stories from USA TODAY through your voice 
Social links
Follow podcast
Recent clips
Browse 18,027 clip(s)